306 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
, and. the tax impact of the reconciling items. Management believes that this non-GAAP financial information is important in comparing current results … before income taxes
Income tax expense
Net loss
Loss per common share:
Basic and diluted
Weighted-average common shares:
Basic and diluted
HARVARD
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
of intangibles related to acquisitions, litigation settlement, restructuring and other costs, gain/loss on equity securities, income taxes and the tax … EBITDA $84,097 $84,908 $113,335 $118,904 $102,100 Revenue 13.0% 8.4% 9.6% 15.4% 15.3% Adjusted EBITDA margin (2) (1) Adjusted income taxes includes the tax
8-K
EX-99.1
7o9ov1r9gc measdo
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
gkjc3qfg3
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
8-K
EX-10.1
p5hciof
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-99.1
2nactrwoqgd42xne6
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
eyaawb5xsi
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
9xfmh5lxpeyi97vu
4 Aug 22
Harvard Bioscience Announces Second Quarter 2022 Financial Results
7:01am
8-K
EX-10.1
1zj5ms1cl
17 May 22
Departure of Directors or Certain Officers
4:39pm